# Rianlon

> Rianlon is a VC fund in Nankai backing Biopharma, Biotechnology and Industrial. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Nankai, China
- Total investments: 3
- Last investment: May 2026
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/rianlon-corporation
- Website: http://www.rianlon.com/

Rianlon is a VC fund in Nankai focused on Biopharma and Biotechnology. Rianlon their product includes antioxidants (RIANOX), light stabilizers (RIASORB) and U-pack which is customized blending formulation to provide one-stop anti-aging solution.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 2 | 67% |
| Biotechnology | 2 | 67% |
| Industrial | 1 | 33% |
| Life Science | 1 | 33% |
| Manufacturing | 1 | 33% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 67% |
| Series A | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Plastic New Technology | Suxin Technology focuses on the enzymatic depolymerization and recycling of post-consumer waste polyester textiles and other polymeric materials. |  | Series A | May 11, 2026 |  |
| Heng Hai Kai Wu | HengHai Kaiwu is a new biomanufacturing firm that uses its own in vitro biotransformation (iVBT) technology to research, develop, and manufacture food, health goods, new chemical materials, and enzyme preparations. |  | Seed | Jan 15, 2026 |  |
| Yuantian Bio | Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation. | $13.7M | Seed | Apr 16, 2025 |  |

3 of 3 investments shown.

## Co-investors
- [Haitang Fund](https://shizune.co/investors/profile/haitang-fund) — VC Fund, 3 deals together
- [Shangshi Fund](https://shizune.co/investors/profile/shangshi-fund) — VC Fund, 3 deals together
- [Tianjin Renai Capital](https://shizune.co/investors/profile/renai-capital) — VC Fund, 2 deals together
- [Dalton Venture](https://shizune.co/investors/profile/dalton-venture) — VC Fund, 1 deal together
- Fu Yuan Investment — VC Fund, 1 deal together
- [Innoangel Fund](https://shizune.co/investors/profile/innoangel-fund) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Rianlon invest in?

Rianlon invests primarily in Biopharma, Biotechnology and Industrial startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Rianlon last invest?

The most recent investment recorded for Rianlon closed in May 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co